Findings reveal fluoxetine’s weak antiviral effects in COVID-19, with no significant benefits in symptom resolution compared to other antiviral treatments.
Rutgers researchers devise strategy to boost prostate cancer treatment efficacy
Rutgers researchers can predict which patients will benefit from a popular prostate cancer drug – and have devised a strategy that may make the treatment